DH
PepLib Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Partnered Radioligand Therapy Asset | Oncology (assumed) | Pre-clinical (assumed) |
| Eli Lilly Collaboration Program(s) | Not Disclosed | Discovery/Pre-clinical |
| AstraZeneca Collaboration Program(s) | Not Disclosed | Discovery/Pre-clinical |